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Psoriasis is a common chronic inflammatory skin disease with a strong genetic component. Few psoriasis-suscep-
tibility loci have been reported, and only two have been confirmed in independent data sets. This article reports
results of a genomewide scan that was performed, using 370 microsatellite markers, for psoriasis-susceptibility loci
in 32 German extended families, comprising 162 affected and 195 unaffected individuals. Nonparametric linkage
analysis of all families provided strong evidence for a novel psoriasis-susceptibility locus on chromosome 19p
( ; ). Parametric analysis revealed a heterogeneity LOD score of 4.06, corresponding to aZ p 3.50 Pp .0002lr
genomewide significance level of .037, under the assumption of a recessive model with high disease-allele frequency
and 66% as the proportion of linked families. This study confirms linkage of psoriasis to the HLA region on
chromosome 6p and suggests additional regions on chromosomes 8q and 21q for further investigations.
Psoriasis vulgaris (MIM 177900) is a chronic inflam-
matory skin disease with a prevalence of ∼2%–3% in
white populations (Lomholt 1963; Nevitt and Hutch-
inson 1996). The hallmarks of psoriasis are a clonal T
cell expansion and infiltration of the epidermis, as well
as a benign hyperproliferation of keratinocytes. Clini-
cally, the disease is characterized by red, scaly plaques,
and it may be associated with severe arthritis. The mul-
tifactorial etiology of psoriasis is well established. Al-
though environmental factors, such as streptococcal in-
fections (Boehncke et al. 1997), have been shown to
affect the onset of the disease, family studies clearly in-
dicate that psoriasis has a strong genetic component
(Abele et al. 1963; Farber et al. 1974; Brandrup et al.
1978). Several psoriasis-susceptibility loci on chromo-
somes 6p (PSORS1 [MIM 177900] [Trembath et al.
1997; Nair et al. 1997]), 17q (PSORS2 [MIM 602723]
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[Tomfohrde et al. 1994]), and 4q (PSORS3 [MIM
601454] [Matthews et al. 1996]) have been described,
and additional putative psoriasis candidate loci have
been reported on 16q, 20p (Nair et al. 1997), 8q (Trem-
bath et al. 1997), 1q (PSORS4 [MIM 603935] [Capon
et al. 1999]), and 3q (PSORS5 [MIM 604316] [Enlund
et al. 1999]). The genes responsible for susceptibility to
psoriasis have not yet been identified.
The inheritance of psoriasis is complex; this com-
plexity arises because variations in the phenotypic ex-
pression of the disease, genetic heterogeneity, and in-
teractions either between genetic factors and the
environment or among genes do not allow a simple cor-
relation of the disease phenotype with the genotypic con-
stitution (Lander and Schork 1994). As with other ge-
netically complex diseases, the interpretation of linkage
data obtained from genome scans for psoriasis suscep-
tibility has been encumbered by many analytical prob-
lems. A consensus has therefore been reached that link-
age findings in complex diseases require confirmation in
independent data sets (Morton 1998). It is noteworthy
that only two psoriasis-susceptibility loci, PSORS1 and
PSORS2, have been confirmed in replication studies.We
have therefore conducted a genomewide scan for pso-
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Figure 1 Summary of the genome scan for psoriasis-susceptibility loci in 32 German extended families. The figure shows nonparametric
multipoint GENEHUNTER PLUS Zlr (A) and LOD* score (B), across all autosomes, from pter to qter. Dotted lines indicate chromosome
boundaries.
riasis-susceptibility loci in a cohort of 32 extended, mul-
tiply affected pedigrees from northern Germany.
After obtaining approval from the ethics committees
of all hospitals involved in the study and after obtaining
informed consent from affected individuals, we identi-
fied families via an index patient and selected those with
at least three affected individuals in two to four gener-
ations. Home visits were arranged, and all participating
family members underwent a clinical examination, with
particular attention to the sites where psoriasis most
commonly appears, such as the scalp, elbows, knees, and
nails. The diagnosis of psoriasis was made if two ormore
predilection sites were affected in a characteristicmanner
or if a single lesion covered 11%of the total body surface
area. Unaffected relatives 120 years old, as well as all
affected individuals, were enrolled in the study. The age
restriction was imposed because the penetrance of pso-
riasis at age !20 years has been estimated to be only
∼50% (Lomholt 1963). Families with psoriasis pustu-
losa were excluded from this study.
A genomewide scan for linkage was performed, using
370 microsatellite markers with an average marker in-
terval of 10 cM and a mean heterozygosity of .8. In
chromosomal regions of interest, the study population
was genotyped with additional markers to further define
those loci. All marker genotypes were checked for Men-
delian inheritance by use of the PedCheck software
(O’Connell and Weeks 1998). Nonparametric multi-
point linkage analysis was performed, using uniform al-
lele frequencies, with the GENEHUNTER-PLUS (Kong
and Cox 1997) modification of GENEHUNTER (Krug-
lyak et al. 1996). One family was split to ensure that
the program retained all affected individuals in the anal-
ysis. GENEHUNTER uses the nonparametric Zall sta-
tistic to estimate the significance of excess sharing of
alleles identical by descent among all affected relatives
(Kruglyak et al. 1996). Because the GENEHUNTER
method produces conservative estimates when the de-
scent information is incomplete, the GENEHUNTER-
PLUS software uses the modified Zlr statistic that is
well approximated by a normal distribution. GENE-
HUNTER-PLUS provides an accurate likelihood-ratio
test to assess evidence for linkage and also allows the
calculation of a nonparametric LOD score that is based
on allele sharing and that can be interpreted in the same
way as a traditional LOD score. The results of the non-
parametric analysis are summarized in figure 1. Themost
significant allele sharing among affected relatives in fam-
ilies was detected at a novel locus on chromosome
19p13, near marker D19S916 ( ; ).Z p 3.50 Pp .0002lr
This finding provided suggestive evidence for linkage.
Because the nonparametric analysis includes information
only from affected individuals, its power to detect link-
age is expected to be lower than the power of parametric
approaches that use information from all available rel-
atives. However, the power to detect linkage by para-
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Figure 2 Linkage analysis on chromosome 19, showing GENE-
HUNTER nonparametric LOD* score (Zall) and HLOD score, assum-
ing a recessive model with high disease-allele frequency, as well as
GENEHUNTER PLUS Zlr and nonparametric LOD score. Markers
are arranged in map order, according to the final Ge´ne´thon human
linkage map (Dib et al. 1996).
metric LOD score analysis is sensitive to misspecification
of the genetic model. It has been shown that maximi-
zation of LOD scores over multiple genetic models (max-
imized LOD [MOD] score) increases the power to detect
linkage when the true mode of inheritance of the disease
is unknown (Hodge et al. 1997). We have thereforemax-
imized parametric multipoint LOD scores over pene-
trance models, using GENEHUNTER version 2.0 (Krug-
lyak et al. 1996). First, the penetrances were altered by
a grid space of 0.1. The model leading to the highest
LOD score was then varied, using a finer grid. In ad-
dition, the phenocopy rate was varied. Finally, we op-
timized the MOD score by changing allele frequencies.
Under the assumption of locus heterogeneity, multipoint
LOD scores (heterogeneity [HLOD]) were maximized
for varying fractions of linked families (a), by use of
GENEHUNTER version 2.0. On chromosome 19p, a
MOD score of 2.38 was obtained at marker D19S865
(31.9 cM from pter), under the assumption of a recessive
inheritance model with high disease-allele frequency.The
HLOD score on 19p was 4.06, with of linkedap 66%
families (figure 2). To address the concern about the
magnitude of the type 1 error after multiple markers and
multiple genetic models were tested, the significance level
of the maximum HLOD score was assessed by simula-
tion. With the use of information from all 33 families,
genotype data were generated by SIMULATE (Ott
1989), under the assumption of no linkage. Maximum
HLOD scores were computed for the models used in the
actual analysis by use of MSIM and ELODHET of the
SLINK software (Ott 1989; Weeks et al. 1990). An em-
pirical significance level was calculated as the proportion
of replicates for which the maximum HLOD for any
model was greater than the maximum obtained in the
real data set and was corrected for testingmultiplemark-
ers. The genomewide probability of obtaining an HLOD
of 4.06 by chance in the present set of families and for
all models tested in the actual analysis was estimated,
using 20,000 replicates, to be !.037. This finding pro-
vides significant evidence, based on stringent criteria, for
a novel psoriasis-susceptibility locus on 19p (Lander and
Kruglyak 1995).
The maximum HLOD was detected under the as-
sumption of a recessive model with high disease-gene
frequency. Although our parametric analysis does not
allow conclusions about the true underlying mode of
inheritance, it is interesting to note that the best model
is consistent with the recessive-gene hypothesis proposed
by Swanbeck et al. (1994). Epidemiological observations
suggest that a recessive mode of inheritance of very com-
mon disease alleles would result in a pseudodominant
inheritance pattern (Swanbeck et al. 1994). The new
psoriasis locus on 19p13 coincides with a susceptibility
locus for inflammatory bowel disease (Rioux et al.
2000). This finding supports the hypothesis proposed by
Nair et al., on the basis of linkage findings on 16q for
both psoriasis (Nair et al. 1997) and Crohn disease (Hu-
got et al. 1996), that common genetic factors may in-
fluence susceptibility to both systemic inflammatory con-
ditions. The candidate interval on 19p is still quite large,
comprising 15 cM. Numerous genes and expressed
sequence tags have been localized to this region. It is
noteworthy that intercellular adhesion molecule-1
(ICAM-1) maps to the interval between D19S413 (31.9
cM from pter) and D19S221 (35.5 cM from pter) (De-
loukas et al. 1998). ICAM-1, a glycoprotein of the im-
munoglobulin superfamily, is expressed on leukocytes,
endothelium, and fibroblasts and is a ligand for lym-
phocyte function–associated (LFA) antigens. Through
the interaction with LFA-1, ICAM-1 functions as a ma-
jor cell-adhesion molecule, mediating leukocyte migra-
tion into sites of inflammation (Springer 1994), T cell
activation (Siu et al. 1989), and T cell–effector function
(Ybarrondo et al. 1994). It has been proposed that ker-
atinocytes participate in the immunohomeostasis of the
skin and in the regulation of T cell activation (Nickoloff
et al. 1995). In psoriasis, ICAM-1 is expressed on the
surface of keratinocytes, and Nickoloff et al. (1993)
have suggested that ICAM-1 has a major role in the
keratinocyte-mediated costimulation of T cell prolifer-
ation. ICAM-1 therefore represents an interesting po-
sitional and functional candidate, on 19p, for psoriasis
susceptibility. Transmission disequilibrium studies on an
extended sample are under way to further elucidate the
role of the ICAM-1 gene in psoriasis.
In addition, suggestive evidence of linkage was de-
tected on chromosomes 6p, 21q, and 8q (table 1). Of
20,000 replicates, 16 had an HLOD of 2.5. Because
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Table 1
Summary of Nonparametric and Parametric Linkage Analysis for Regions on Chromosomes 6, 8, 19, and 21 with






NONPARAMETRIC STATISTICS PARAMETRIC STATISTICS
Zall
b Zlr






D6S260 29.6 2.03 2.30 .012 1.15
D6S422 35.7 3.07 3.10 .001 2.08 2.46 .02, .1, .6 .01 2.93 .75
8:
D8S286 93.5 1.78 1.52 .064 .50 3.13 .03, .15, .3 .001 3.15 .85
D8S270 102.1 2.02 1.97 .024 .84
19:
D19S922 26.0 3.12 3.17 .0008 2.18
D19S916 30.8 3.62 3.50 .0002 2.64
D19S865 31.9 3.60 3.46 .0003 2.60 2.38 .03, .1, 1.0 .04 4.06 .66
D19S221 35.5 3.06 2.86 .0021 1.78
D19S840 37.3 3.07 2.90 .0019 1.82
D19S226 41.7 2.74 2.78 .0027 1.68
21:
D21S236 2.6 2.06 2.43 .0075 1.28
D21S1256 8.6 2.02 2.48 .0066 1.33 2.84 .03, .1, .95 .98, .02 3.35 .73
a According to the final Ge´ne´thon human linkage map (Dib et al. 1996).
b According to GENEHUNTER.
c According to GENEHUNTER PLUS.
d Statistical significance of the Zlr score.
we tested 370 markers, an HLOD of 2.5 corresponds
to a genomewide P value of .296, according to our
simulation. Increased allele sharing was observed at
marker D6S422 in the HLA region where studies in-
volving two independent genome scans have reported
linkage to psoriasis (Nair et al. 1997; Trembath et al.
1997). A MOD score of 2.46 was obtained, under the
assumption of a recessive mode of inheritance. Anal-
ogous to other investigators (Leder et al. 1998), we
found no significant evidence for heterogeneity on 6p.
Given that the replication of previously reported loci
requires less stringent criteria for significance (Lander
and Kruglyak 1995), our finding confirms the presence
of a major psoriasis locus in this region. Additional
investigations will be required to confirm the relevance
of the chromosomal regions on 21q and 8q for psoriasis
susceptibility.
The present study in a large cohort of German ex-
tended families with high rates of psoriasis provides sig-
nificant evidence for a novel psoriasis-susceptibility locus
on 19p, which awaits replication in independent data
sets. In addition, linkage to the HLA region on 6p was
confirmed, demonstrating the importance of this region
for psoriasis susceptibility.
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